XML 6 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Offerings
Aug. 13, 2024
USD ($)
shares
Offering: 1  
Offering:  
Fee Previously Paid false
Rule 457(r) true
Security Type Debt
Security Class Title 4.150% notes due 2027
Amount Registered | shares 750,000,000
Proposed Maximum Offering Price per Unit 0.99919
Maximum Aggregate Offering Price $ 749,392,500
Fee Rate 0.01476%
Amount of Registration Fee $ 110,610.33
Offering Note
  (1)
These “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in Eli Lilly and Company’s Registration Statement on Form
S-3
(File
No. 333-262943),
which was filed on February 24, 2022, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
Offering: 2  
Offering:  
Fee Previously Paid false
Rule 457(r) true
Security Type Debt
Security Class Title 4.200% notes due 2029
Amount Registered | shares 1,000,000,000
Proposed Maximum Offering Price per Unit 0.99781
Maximum Aggregate Offering Price $ 997,810,000
Fee Rate 0.01476%
Amount of Registration Fee $ 147,276.76
Offering Note
  (1)
These “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in Eli Lilly and Company’s Registration Statement on Form
S-3
(File
No. 333-262943),
which was filed on February 24, 2022, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
Offering: 3  
Offering:  
Fee Previously Paid false
Rule 457(r) true
Security Type Debt
Security Class Title 4.600% notes due 2034
Amount Registered | shares 1,250,000,000
Proposed Maximum Offering Price per Unit 0.99968
Maximum Aggregate Offering Price $ 1,249,600,000
Fee Rate 0.01476%
Amount of Registration Fee $ 184,440.96
Offering Note
  (1)
These “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in Eli Lilly and Company’s Registration Statement on Form
S-3
(File
No. 333-262943),
which was filed on February 24, 2022, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
Offering: 4  
Offering:  
Fee Previously Paid false
Rule 457(r) true
Security Type Debt
Security Class Title 5.050% notes due 2054
Amount Registered | shares 1,250,000,000
Proposed Maximum Offering Price per Unit 0.99510
Maximum Aggregate Offering Price $ 1,243,875,000
Fee Rate 0.01476%
Amount of Registration Fee $ 183,595.95
Offering Note
  (1)
These “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in Eli Lilly and Company’s Registration Statement on Form
S-3
(File
No. 333-262943),
which was filed on February 24, 2022, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.
Offering: 5  
Offering:  
Fee Previously Paid false
Rule 457(r) true
Security Type Debt
Security Class Title 5.200% notes due 2064
Amount Registered | shares 750,000,000
Proposed Maximum Offering Price per Unit 0.99966
Maximum Aggregate Offering Price $ 749,745,000
Fee Rate 0.01476%
Amount of Registration Fee $ 110,662.36
Offering Note
  (1)
These “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in Eli Lilly and Company’s Registration Statement on Form
S-3
(File
No. 333-262943),
which was filed on February 24, 2022, in accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended. The prospectus supplement to which this exhibit is attached is a final prospectus for the related offering.